Regencell Bioscience (NASDAQ:RGC) Stock Price Up 14.6% – Still a Buy?

Regencell Bioscience Holdings Limited (NASDAQ:RGC)’s stock price rose 14.6% on Tuesday . The company traded as high as $32.78 and last traded at $31.00. Approximately 295,348 shares were traded during trading, a decline of 59% from the average daily volume of 725,313 shares. The stock had previously closed at $27.04.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Regencell Bioscience in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Regencell Bioscience presently has a consensus rating of “Sell”.

Regencell Bioscience Price Performance

The company’s fifty day moving average is $17.39 and its 200 day moving average is $16.15.

Institutional Trading of Regencell Bioscience

Several large investors have recently added to or reduced their stakes in RGC. Greenfield Savings Bank acquired a new position in shares of Regencell Bioscience during the second quarter worth about $187,000. Y Intercept Hong Kong Ltd purchased a new stake in shares of Regencell Bioscience during the 2nd quarter valued at about $222,000. XTX Topco Ltd acquired a new position in Regencell Bioscience during the 3rd quarter worth approximately $598,000. BNP Paribas Financial Markets purchased a new position in Regencell Bioscience in the 2nd quarter worth approximately $768,000. Finally, Squarepoint Ops LLC purchased a new position in Regencell Bioscience in the 2nd quarter worth approximately $1,701,000. 0.13% of the stock is currently owned by institutional investors and hedge funds.

Regencell Bioscience Company Profile

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.